| Product Code: ETC6415155 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bhutan Circulating Tumor DNA (ctDNA) Market Overview |
3.1 Bhutan Country Macro Economic Indicators |
3.2 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, 2021 & 2031F |
3.3 Bhutan Circulating Tumor DNA (ctDNA) Market - Industry Life Cycle |
3.4 Bhutan Circulating Tumor DNA (ctDNA) Market - Porter's Five Forces |
3.5 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.7 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Bhutan Circulating Tumor DNA (ctDNA) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Bhutan |
4.2.2 Growing awareness about the benefits of circulating tumor DNA (ctDNA) testing |
4.2.3 Advancements in healthcare infrastructure and technology in Bhutan |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas of Bhutan |
4.3.2 High cost associated with ctDNA testing in Bhutan |
4.3.3 Lack of skilled healthcare professionals for interpreting ctDNA test results |
5 Bhutan Circulating Tumor DNA (ctDNA) Market Trends |
6 Bhutan Circulating Tumor DNA (ctDNA) Market, By Types |
6.1 Bhutan Circulating Tumor DNA (ctDNA) Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Routine Screening, 2021- 2031F |
6.1.4 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Patient Work Up, 2021- 2031F |
6.1.5 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Early-Stage Disease, 2021- 2031F |
6.1.6 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Late Stage/Metastatic Disease, 2021- 2031F |
6.2 Bhutan Circulating Tumor DNA (ctDNA) Market, By Sample |
6.2.1 Overview and Analysis |
6.2.2 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Blood, 2021- 2031F |
6.2.3 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Urine, 2021- 2031F |
6.2.4 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Bhutan Circulating Tumor DNA (ctDNA) Market, By Method |
6.3.1 Overview and Analysis |
6.3.2 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Sample Preparation, 2021- 2031F |
6.3.3 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Ultra-Low Passage Whole Genome Sequencing,, 2021- 2031F |
6.3.4 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By ctDNA Quantification, 2021- 2031F |
6.3.5 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Copy Number Analysis, 2021- 2031F |
6.3.6 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Statistical Analysis, 2021- 2031F |
6.4 Bhutan Circulating Tumor DNA (ctDNA) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.4 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Academia, 2021- 2031F |
6.4.5 Bhutan Circulating Tumor DNA (ctDNA) Market Revenues & Volume, By Research Centers, 2021- 2031F |
7 Bhutan Circulating Tumor DNA (ctDNA) Market Import-Export Trade Statistics |
7.1 Bhutan Circulating Tumor DNA (ctDNA) Market Export to Major Countries |
7.2 Bhutan Circulating Tumor DNA (ctDNA) Market Imports from Major Countries |
8 Bhutan Circulating Tumor DNA (ctDNA) Market Key Performance Indicators |
8.1 Average turnaround time for ctDNA test results in Bhutan |
8.2 Number of healthcare facilities offering ctDNA testing services in Bhutan |
8.3 Adoption rate of ctDNA testing among oncologists in Bhutan |
9 Bhutan Circulating Tumor DNA (ctDNA) Market - Opportunity Assessment |
9.1 Bhutan Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Bhutan Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.3 Bhutan Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By Method, 2021 & 2031F |
9.4 Bhutan Circulating Tumor DNA (ctDNA) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Bhutan Circulating Tumor DNA (ctDNA) Market - Competitive Landscape |
10.1 Bhutan Circulating Tumor DNA (ctDNA) Market Revenue Share, By Companies, 2024 |
10.2 Bhutan Circulating Tumor DNA (ctDNA) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here